Compare CNDT & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNDT | LAB |
|---|---|---|
| Founded | 2016 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 448.6M | 449.9M |
| IPO Year | N/A | 2011 |
| Metric | CNDT | LAB |
|---|---|---|
| Price | $2.02 | $1.45 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $1.35 |
| AVG Volume (30 Days) | 1.2M | ★ 2.0M |
| Earning Date | 11-07-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,072,000,000.00 | $169,737,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.37 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 79.77 |
| 52 Week Low | $1.72 | $0.92 |
| 52 Week High | $4.90 | $2.25 |
| Indicator | CNDT | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 48.34 | 59.98 |
| Support Level | $1.95 | $1.43 |
| Resistance Level | $2.07 | $1.51 |
| Average True Range (ATR) | 0.10 | 0.08 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 68.75 | 61.40 |
Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.